356 related items for PubMed ID: 2153693
21. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[Abstract] [Full Text] [Related]
22. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time.
Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP.
J Clin Endocrinol Metab; 1996 May; 81(5):1912-7. PubMed ID: 8626857
[Abstract] [Full Text] [Related]
23. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
Buyalos RP, Jackson RV, Grice GI, Hockings GI, Torpy DJ, Fox LM, Boots LR, Azziz R.
J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
[Abstract] [Full Text] [Related]
24. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
Azziz R, Black V, Hines GA, Fox LM, Boots LR.
J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
[Abstract] [Full Text] [Related]
25. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.
Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL.
J Clin Endocrinol Metab; 1997 Apr; 82(4):1279-83. PubMed ID: 9100607
[Abstract] [Full Text] [Related]
26. Evaluation of hypothalamic-pituitary-adrenal axis in amenorrhoeic women with insulin-dependent diabetes.
la Marca A, Morgante G, De Leo V.
Hum Reprod; 1999 Feb; 14(2):298-302. PubMed ID: 10099967
[Abstract] [Full Text] [Related]
27. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[Abstract] [Full Text] [Related]
28. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[Abstract] [Full Text] [Related]
29. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
Laughlin GA, Dominguez CE, Yen SS.
J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
[Abstract] [Full Text] [Related]
30. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation.
Reame NE, Sauder SE, Case GD, Kelch RP, Marshall JC.
J Clin Endocrinol Metab; 1985 Nov; 61(5):851-8. PubMed ID: 3900122
[Abstract] [Full Text] [Related]
31. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.
Brigell DF, Fang VS, Rosenfield RL.
J Clin Endocrinol Metab; 1992 May; 74(5):1036-9. PubMed ID: 1314844
[Abstract] [Full Text] [Related]
32. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[Abstract] [Full Text] [Related]
33. Comparison of adrenocorticotropin and adrenal steroid responses to corticotropin-releasing hormone versus metyrapone testing in patients with hypopituitarism.
Riddick L, Chrousos GP, Jeffries S, Pang S.
Pediatr Res; 1994 Aug; 36(2):215-20. PubMed ID: 7970937
[Abstract] [Full Text] [Related]
34. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
Wirtz PH, Siegrist J, Schuhmacher A, Hoefels S, Maier W, Zobel AW.
Psychoneuroendocrinology; 2010 May; 35(4):536-43. PubMed ID: 19818562
[Abstract] [Full Text] [Related]
35. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F.
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[Abstract] [Full Text] [Related]
36. Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome.
Rabin DS, Schmidt PJ, Campbell G, Gold PW, Jensvold M, Rubinow DR, Chrousos GP.
J Clin Endocrinol Metab; 1990 Nov; 71(5):1158-62. PubMed ID: 2172272
[Abstract] [Full Text] [Related]
37. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
Rotllant J, Balm PH, Ruane NM, Pérez-Sánchez J, Wendelaar-Bonga SE, Tort L.
Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
[Abstract] [Full Text] [Related]
38. Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea.
Genazzani AD, Stomati M, Bersi C, Luisi S, Fedalti M, Santuz M, Esposito G, Petraglia F, Genazzani AR.
J Endocrinol Invest; 2000 Sep; 23(8):526-32. PubMed ID: 11021769
[Abstract] [Full Text] [Related]
39. Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity.
Nappi RE, Petraglia F, Genazzani AD, D'Ambrogio G, Zara C, Genazzani AR.
Fertil Steril; 1993 Mar; 59(3):571-6. PubMed ID: 8384575
[Abstract] [Full Text] [Related]
40. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI, Ferries LM, Roberts B, Qualls CR, Veldhuis JD, Lisansky EJ.
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
